Closing the Gap: Results of the Multicenter Canadian Randomized Controlled Trial of Structured Transition in Young Adults With Type 1 Diabetes.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
06 2019
Historique:
received: 19 10 2018
accepted: 08 03 2019
pubmed: 24 4 2019
medline: 26 3 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

To determine if a structured transition program for young adults with type 1 diabetes improves clinic attendance, glycemic control, diabetes-related distress, quality of life, and satisfaction with care. In this multicenter randomized controlled trial, young adults (17-20 years) with type 1 diabetes were randomly assigned to a transition program with a transition coordinator or to standard care. The intervention lasted 18 months (6 in pediatric and 12 in adult care). The primary outcome was the proportion of participants who failed to attend at least one adult diabetes clinic visit during the 12-month follow-up after completion of the intervention. We randomized 205 participants, 104 to the transition program and 101 to standard care. Clinic attendance was improved in the transition program (mean [SD] number of visits 4.1 [1.1] vs. 3.6 [1.2], Transition support during this 18-month intervention was associated with increased clinic attendance, improved satisfaction with care, and decreased diabetes-related distress, but these benefits were not sustained 12 months after completion of the intervention.

Identifiants

pubmed: 31010873
pii: dc18-2187
doi: 10.2337/dc18-2187
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0

Banques de données

ClinicalTrials.gov
['NCT01351857']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1018-1026

Investigateurs

T Spaic (T)
T Robinson (T)
E B Goldbloom (EB)
P Gallego (P)
I Hramiak (I)
M L Lawson (ML)
J Malcolm (J)
J L Mahon (JL)
D Morrison (D)
A Parikh (A)
A Simone (A)
R Stein (R)
A Uvarov (A)
C L Clarson (CL)
Tamara Spaic (T)
Tracy Robinson (T)
Ellen Goldbloom (E)
Patricia Gallego (P)
Irene Hramiak (I)
Margaret Lawson (M)
Janine Malcolm (J)
Jeffrey Mahon (J)
Deric Morrison (D)
Amish Parikh (A)
Angelo Simone (A)
Robert Stein (R)
Artem Uvarov (A)
Cheril Clarson (C)

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Tamara Spaic (T)

Division of Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada tamara.spaic@sjhc.london.on.ca.
Department of Medicine, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.

Tracy Robinson (T)

Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.

Ellen Goldbloom (E)

Division of Endocrinology and Metabolism, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
University of Ottawa, Ottawa, Ontario, Canada.

Patricia Gallego (P)

Lawson Health Research Institute, London, Ontario, Canada.
Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
Department of Paediatrics, Western University, London, Ontario, Canada.

Irene Hramiak (I)

Division of Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada.
Department of Medicine, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.

Margaret L Lawson (ML)

Division of Endocrinology and Metabolism, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
University of Ottawa, Ottawa, Ontario, Canada.

Janine Malcolm (J)

University of Ottawa, Ottawa, Ontario, Canada.
The Ottawa Hospital, Ottawa, Ontario, Canada.

Jeffrey Mahon (J)

Division of Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada.
Department of Medicine, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.

Deric Morrison (D)

Division of Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada.
Department of Medicine, Western University, London, Ontario, Canada.

Amish Parikh (A)

Trillium Health Partners, Mississauga, Ontario, Canada.

Angelo Simone (A)

Trillium Health Partners, Mississauga, Ontario, Canada.

Robert Stein (R)

Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
Department of Paediatrics, Western University, London, Ontario, Canada.

Artem Uvarov (A)

Department of Medicine, Western University, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH